Washington Trust’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-50
Closed -$1.81K 877
2023
Q3
$1.81K Sell
50
-1
-2% -$37 ﹤0.01% 770
2023
Q2
$1.92K Hold
51
﹤0.01% 789
2023
Q1
$2.36K Buy
51
+7
+16% +$327 ﹤0.01% 789
2022
Q4
$2.04K Sell
44
-2
-4% -$91 ﹤0.01% 813
2022
Q3
$2K Buy
46
+5
+12% +$230 ﹤0.01% 793
2022
Q2
$2K Sell
41
-7
-15% -$297 ﹤0.01% 801
2022
Q1
$2K Sell
48
-65
-58% -$3.01K ﹤0.01% 824
2021
Q4
$6K Buy
113
+1
+0.9% +$50 ﹤0.01% 721
2021
Q3
$5K Sell
112
-8
-7% -$397 ﹤0.01% 856
2021
Q2
$5K Sell
120
-14
-10% -$634 ﹤0.01% 864
2021
Q1
$6K Buy
134
+46
+52% +$1.91K ﹤0.01% 806
2020
Q4
$4K Buy
88
+6
+7% +$237 ﹤0.01% 815
2020
Q3
$3K Sell
82
-3
-4% -$118 ﹤0.01% 839
2020
Q2
$3K Buy
85
+4
+5% +$135 ﹤0.01% 744
2020
Q1
$2K Buy
+81
New +$3.17K ﹤0.01% 831
2018
Q3
Sell
-43
Closed -$1K 450
2018
Q2
$1K Buy
+43
New +$1.33K ﹤0.01% 872

Other funds holding G

Washington Trust's G Position: Q4 2023 in Review

Washington Trust sold out of Genpact (G) in Q4 2023, closing a stake of 50 shares — an estimated $1.81K sold.

Washington Trust first reported a position in G in Q2 2018 and held it in 16 quarters. The position peaked at $6K in Q4 2021. 354 funds tracked by Wall St. Rank hold G as of Q4 2023.

  • Washington Trust reported no remaining Genpact position as of Q4 2023 after selling out during the quarter.
  • Washington Trust sold 50 Genpact shares in Q4 2023, an estimated $1.81K.
  • Washington Trust first reported a position in Genpact in Q2 2018 and held it in 16 quarters.
  • Washington Trust's Genpact position peaked at $6K in Q4 2021.
  • 354 funds tracked by Wall St. Rank held Genpact as of Q4 2023.

Based on Washington Trust's 13F filing for Q4 2023, filed 18 Jan 2024.